CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 242 filers reported holding CYTOKINETICS INC in Q1 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,997,989 | +4.6% | 1,052,206 | +15.8% | 0.00% | 0.0% |
| Q2 2023 | $29,627,148 | +3.7% | 908,251 | +11.8% | 0.00% | 0.0% |
| Q1 2023 | $28,582,867 | -50.7% | 812,244 | -35.8% | 0.00% | -57.1% |
| Q4 2022 | $58,001,799 | -15.1% | 1,265,862 | -10.2% | 0.01% | -22.2% |
| Q3 2022 | $68,330,000 | +15.9% | 1,410,366 | -6.0% | 0.01% | +12.5% |
| Q2 2022 | $58,939,000 | +36.8% | 1,500,105 | +28.1% | 0.01% | +33.3% |
| Q1 2022 | $43,098,000 | +8.5% | 1,170,819 | +34.3% | 0.01% | +20.0% |
| Q4 2021 | $39,730,000 | +32.2% | 871,662 | +3.7% | 0.01% | +25.0% |
| Q3 2021 | $30,054,000 | +63.3% | 840,924 | -9.6% | 0.00% | +100.0% |
| Q2 2021 | $18,404,000 | +12.5% | 929,960 | +32.2% | 0.00% | 0.0% |
| Q1 2021 | $16,358,000 | -12.0% | 703,217 | -21.4% | 0.00% | -33.3% |
| Q4 2020 | $18,591,000 | +2.1% | 894,677 | +6.4% | 0.00% | -25.0% |
| Q3 2020 | $18,209,000 | +9.6% | 841,077 | +19.3% | 0.00% | 0.0% |
| Q2 2020 | $16,612,000 | +46.5% | 704,787 | -26.7% | 0.00% | +33.3% |
| Q1 2020 | $11,337,000 | -21.8% | 961,655 | -29.6% | 0.00% | 0.0% |
| Q4 2019 | $14,499,000 | +361.5% | 1,366,528 | +394.9% | 0.00% | +200.0% |
| Q3 2019 | $3,142,000 | -2.4% | 276,108 | -3.5% | 0.00% | 0.0% |
| Q2 2019 | $3,220,000 | +344.8% | 286,236 | +220.0% | 0.00% | – |
| Q1 2019 | $724,000 | -31.6% | 89,450 | -46.6% | 0.00% | – |
| Q4 2018 | $1,059,000 | -25.6% | 167,654 | +16.1% | 0.00% | – |
| Q3 2018 | $1,423,000 | -25.9% | 144,344 | -37.6% | 0.00% | -100.0% |
| Q2 2018 | $1,920,000 | +89.2% | 231,324 | +64.0% | 0.00% | – |
| Q1 2018 | $1,015,000 | -24.5% | 141,059 | -14.6% | 0.00% | – |
| Q4 2017 | $1,345,000 | -59.3% | 165,157 | -27.6% | 0.00% | -100.0% |
| Q3 2017 | $3,308,000 | -6.7% | 228,172 | -22.2% | 0.00% | 0.0% |
| Q2 2017 | $3,547,000 | -51.1% | 293,230 | -48.1% | 0.00% | 0.0% |
| Q1 2017 | $7,256,000 | +38.7% | 564,622 | +31.1% | 0.00% | 0.0% |
| Q4 2016 | $5,230,000 | +960.9% | 430,564 | +702.7% | 0.00% | – |
| Q3 2016 | $493,000 | +575.3% | 53,638 | +601.8% | 0.00% | – |
| Q2 2016 | $73,000 | +9.0% | 7,643 | -19.5% | 0.00% | – |
| Q1 2016 | $67,000 | -94.7% | 9,491 | -92.2% | 0.00% | – |
| Q4 2015 | $1,272,000 | -77.6% | 121,646 | -85.7% | 0.00% | -100.0% |
| Q3 2015 | $5,683,000 | +125.3% | 849,478 | +126.4% | 0.00% | +100.0% |
| Q2 2015 | $2,522,000 | +3.7% | 375,188 | +4.6% | 0.00% | 0.0% |
| Q1 2015 | $2,432,000 | +192.0% | 358,697 | +244.9% | 0.00% | – |
| Q4 2014 | $833,000 | -9.8% | 104,014 | -60.3% | 0.00% | – |
| Q3 2014 | $923,000 | -56.0% | 262,150 | -40.3% | 0.00% | -100.0% |
| Q2 2014 | $2,098,000 | -6.6% | 438,779 | +85.5% | 0.00% | 0.0% |
| Q1 2014 | $2,247,000 | +102.6% | 236,575 | +38.6% | 0.00% | – |
| Q4 2013 | $1,109,000 | -50.0% | 170,662 | -41.7% | 0.00% | -100.0% |
| Q3 2013 | $2,216,000 | – | 292,721 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |